Aster Hospital in Bangalore, India conducts first ever post Covid double lung transplant for 30-year-old Covid warrior doctor

Dr. Sanath Kumar, 30-yr-old Anesthetic from a private hospital in Bangalore had been working tirelessly treating critically ill covid-19 patients in the ICU since the pandemic started

From left to right - Dr. Sanath Kumar along with Dr. Sunil Kumar K, Lead and Sr Consultant - Interventional Pulmonology Transplant Physician; Dr. V Arun, Lead Consultant - Anaesthesia Critical Care

From left to right - Dr. Sanath Kumar along with Dr. Sunil Kumar K, Lead and Sr Consultant - Interventional Pulmonology & Transplant Physician; Dr. V Arun, Lead Consultant - Anaesthesia & Critical Care

Dubai: Doctors at Aster CMI Hospital, one of Aster DM Healthcare’s 27 multispecialty hospitals, have successfully carried out first ever post covid double lung transplant on a covid warrior, who is also a medical professional. Dr. Sanath Kumar, 30-yr-old Anesthetic from a private hospital in Bangalore had been working tirelessly treating critically ill covid-19 patients in the ICU since the pandemic started. Unfortunately, in the course of his work, he contracted coronavirus during the second wave which eventually caused lung damage, requiring urgent transplantation.

Unaware of having caught the infection, Dr. Sanath started having fever and cough. He was anxious about this and underwent a Covid-19 test which turned out to be positive. Immediately, he started on medications, but his condition worsened over the time. One day he felt a sudden pain in his chest and developed resistant hypoxia. Due to this, his oxygen level decreased significantly to 60% and he was put on a mechanical ventilator for oxygen support. He was then referred to Aster CMI Hospital. Upon arrival, his condition was evaluated, and he was put on ECMO support. He was kept on observation for three-four weeks for any signs of improvement in his lungs. Since his lungs were severely damaged, he needed a double lung transplant for survival.

A team of Critical-care Consultants, Pulmonologists, and Lung Transplant Surgeons at Aster CMI Hospital, Bangalore consisting of Dr. Sandeep Attawar, Dr. V Arun, Dr. Srivatsa Lokeshwaran, Dr. Sunil Kumar K and Dr. Prakash Doraiswamy treated Dr. Sanath Kumar for three and half months, performed double lung transplant and gave him a new lease of life.

Explaining the challenges and complexities involved, Dr. Sandeep Attawar, Chair & Director of Thoracic organ transplants and Assist devices at KIMS Heart & Lung Transplant Institute, said, “A double lung transplant is a grueling surgery and was the only solution for Dr. Sanath, who experienced a life-threatening combination of lung damage caused by the covid-19 virus, an exaggerated immune response to it, and the body’s failure to properly repair the injury. Eventually, in the self-repair phase the deposition of yellow fibrotic scar tissue creates a liver-like densification that makes the lungs completely solid.  This process of misdirected and inappropriate self-repair irreversibly destroys the tiny alveolar air sacs through which gas exchange happens. Patients only survive to the fibrotic stage if they are intubated and at times transitioned to ECMO support. This harmful scarring can occur within a couple of weeks of viral pneumonia. What makes this surgery uniquely complex is the subset of patients that are forced to accept this option. They are intubated, deconditioned, nutritionally inadequate and suffer from airway and blood stream infections during their prolonged hospitalization. Treating these critically ill patients successfully with a double lung transplant, underlines the overall abilities of a high-quality transplant program.”

Dr. V Arun, Lead Consultant - Anaesthesia & Critical Care, Aster CMI Hospital, said, “Dr. Sanath’s case was both emotionally and clinically challenging. Being from the same fraternity working with COVID patients it was difficult to see a colleague whose lung damage had progressed so far. When he was referred to Aster CMI, he was intubated and was on 100% oxygen support but barely having enough oxygen in his bloodstream to survive. Within half an hour of his arrival we initiated ECMO support to help him oxygenate the rest of his body. Despite keeping him on ECMO and resting the lungs they continued to deteriorate. Long term ECMO with a bleak outlook was a difficult period for him and his family.  A transplant was the last option. Luckily he remained stable over the next few weeks while we waited for a suitable donor match for him. We were able to find a suitable match after 4 weeks and he underwent lung transplant.”

Dr. Sunil Kumar K, Lead and Sr Consultant - Interventional Pulmonology & Transplant Physician at Aster CMI Hospital, said, “The transplant was successful with the help of highly skilled doctors and surgeons backed by the high-end medical equipment and infrastructure at Aster CMI. Usually, post-transplant infections and rejections are the major roadblocks for the successful outcomes. Thus, it was very important to comprehensively address each and every challenge. Dr. Sanath’s condition was closely monitored for a few weeks before we mobilized him out of the bed.”

Dr. Srivatsa Lokeshwaran, Consultant - Interventional Pulmonology, & Transplant Physician at Aster CMI Hospital said, “Increasingly, we are seeing patients with chronic lung disease who have no other option for survival and lung transplant has been a second life for patient with chronic lung disease. While waiting for the perfect match and donor, we kept Dr. Sanath on ECMO support to keep him alive. Luckily, he received a good pair of lungs which matched him perfectly. He endured the procedure well and recovered shortly and was discharged from the hospital with no complications,”

Dr. Prakash Doraiswamy, Sr. Consultant - Anaesthesia & Critical Care, Aster CMI Hospital, said, “After a prolonged treatment of three-and-a-half months at the hospital, Dr. Sanath slowly pulled through. The recovery journey was not easy as the amazing outcome was only possible by the absolute dedication of our nursing, physiotherapy and multi-disciplinary team consisting of Anesthetists and Intensivists, Pulmonologists and Transplant Surgical team in bringing him back to his feet.”

Thanking the doctors, Dr. Sanath Kumar said, “When I tested positive and started taking medicines, I thought I will recover soon. I had never imagined that I would suffer severely and end up having a lung transplant. I want to thank all the doctors, surgeons, nurses and other staff at Aster CMI for their support and giving me a second chance to live. I also want to extend my gratitude to my family who stood by me in this journey, without their help all of these would have not been possible.”

Post the transplant, Dr. Sanath stepped out of the hospital. He is at home now with his family but still needs to stay indoors in a secure environment to minimize risk of catching infection again.

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our 27 hospitals, 115 clinics and over 223 pharmacies in seven countries, including India. We have over 21,900 plus dedicated employees including 2970 doctors and 6512 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands. For more information, please visit

For more information about us, please contact:
Lavanya Mandal
Head of PR and Internal Communications
Aster DM Healthcare

Bejoy Changarath
Assistant General Manager - PR & Media Relations
Aster DM Healthcare

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases